Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...

A federal judge has blocked a new bill in Louisiana that would require the Bible's Ten Commandments to be displayed in the ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencel; ...

at the 39 th Annual Meeting for the Society for Immunotherapy in Cancer (SITC2024), being held in Houston Texas from November 8 – 10, 2024. The late-breaking poster presentation focused on results ...

Three people have been charged in an alleged Iran-linked plot to assassinate President-elect Trump and several Iranian dissidents, according to a criminal complaint.

ROSSLARE HARBOUR Ballycogley Players In front of a packed house at the Stella Maris Centre, Kilmore Quay, the curtain came down on what was a hugely successful 1 Act run for the Ballycogley Players.

The next meeting will take place on this Wednesday 13th November at 7.30pm in Oylegate Community Centre. The annual Christmas raffle will be ... from those who are availing of this facility. In ...

STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing ...

Pre-specified Events to Trigger Interim Analysis of Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Remains on Track for Q4 2024 - - Data from the Phase 2a Trial of SLS009 in Relapse ...

Detailed price information for Annovis Bio Inc (ANVS-N) from The Globe and Mail including charting and trades.